Clinical Trial Detail

NCT ID NCT03274479
Title PBF-1129 in Patients With NSCLC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Palobiofarma SL
Indications

lung non-small cell carcinoma

Therapies

PBF-1129

Age Groups: adult senior

No variant requirements are available.